Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent.

Autor:	Lickliter, J. D.1 jason.lickliter@med.monash.edu.au, Francesconi, A. B.2, Smith, G3, Burge, M2, Coulthard, A4, Rose, S4, Griffin, M4, Milne, R5, McCarron, J6, Yeadon, T6, Wilks, A3, Cubitt, A2, Wyld, D. K.2, Vasey, P. A.2
Zdroj:	British Journal of Cancer. 8/24/2010, Vol. 103 Issue 5, p597-606. 10p. 1 Color Photograph, 4 Charts, 3 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu